Transgene

Transgene Days Payable Outstanding

The Days Payable Outstanding (DPO) of Transgene (TNG.PA) as of Nov 19, 2026 is 79.02. In the previous year, Days Payable Outstanding (DPO) was 85.39 — a change of -7.45% (lower).

Days Payable Outstanding

79.02

YoY

-7.45%

Last updated:

Days Payable Outstanding (DPO) of Transgene is 2022 79.02 . Days Payable Outstanding (DPO) of Transgene was 2021 85.39 . It decreases by -7.45% lower compared to the previous year.

The Transgene Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2021
85.39 EUR
Jan 1, 2022
79.02 EUR
The Transgene Days Payable Outstanding history
YEARDays Payable OutstandingYoY
79.02-7.45%
85.39—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transgene Stock analysis

What does Transgene do? Transgene SA is a French biotechnology company specializing in the development and production of therapeutics, with a focus on cancer medications. It has a strong patent portfolio in the field of viral vectors, which are used for targeted gene therapy. The company's main areas of operation are clinical trials, research, and production. Transgene has research and production facilities in Strasbourg and Lyon, with over 100 employees. It has established partnerships with pharmaceutical companies, including Takeda Pharmaceuticals, for the development and marketing of therapeutics. Its flagship product, OncoVir-1®, is an immunomodulator that stimulates the immune system to fight tumor cells. Another promising product is TG4010, a therapeutic vaccine for non-small cell lung carcinoma. Transgene is an emerging company with a promising portfolio of cancer therapeutics, leveraging its expertise in viral vectors and collaborating closely with industry partners to expedite the development of marketable products. Transgene is expected to play a significant role in the development of new and innovative cancer treatments. Transgene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transgene stock

Days Payable Outstanding (DPO) of Transgene is 79.02 in 2022.

Days Payable Outstanding (DPO) of Transgene changed from 85.39 to 79.02, representing a -7.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Transgene since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Transgene with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Transgene

All Key Metrics — Transgene